NRXN Pharmaceuticals Private Limited
About NRXN Pharmaceuticals Private Limited
Data last updated:
NRXN Pharmaceuticals Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 24 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24290UP2020PTC131583. Its GSTIN is 09AAHCN0502E1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Gaurav Kumar (Managing Director) and Neha Varshney.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.L – 2 Shashtri Nagar, Bareilly, Uttar Pradesh, India – 243122.
As per the financials filed for FY 2024, the company reported a revenue of ₹30.68 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹6,420 (net margin 0.2%) and EBITDA of ₹93,236 (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 154% over three years.
Company details
Contact details
NRXN Pharmaceuticals Private Limited's registered office is in Bareilly, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressH.No.L – 2 Shashtri Nagar, Bareilly, Uttar Pradesh, India – 243122
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of NRXN Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of NRXN Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of NRXN Pharmaceuticals Private Limited, buy the company report.
Financials of NRXN Pharmaceuticals Private Limited
FY 2025 filings availableNRXN Pharmaceuticals Private Limited reported revenue of ₹30.68 Lakh (up 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 154% over three years, including 2% growth in the latest year. EBITDA rose 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹93,236 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹6,420 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3% | |||
| Net Profit Margin | 0.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of NRXN Pharmaceuticals Private Limited, buy the company report.
Board of directors of NRXN Pharmaceuticals Private Limited
NRXN Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Kumar | Managing Director | 10 Oct 2020 | 6 Years 0 Months | Current |
| Neha Varshney | Director | 24 Jul 2020 | 6 Years 3 Months | Current |
Peer comparison
NRXN Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Viakos Pharmaceuticals Private Limited | ₹30.87 Lakh (FY 2024) | 71.0% | Mumbai, Maharashtra, India | |||
| Macklin Pharmaceuticals Private Limited | ₹30.74 Lakh (FY 2025) | 37.0% | Kanpur, Uttar Pradesh, India | |||
| NRXN Pharmaceuticals Private Limitedthis company | ₹30.68 Lakh (FY 2024) | ₹6,420 | 0.2% | 2.0% | Bareilly, Uttar Pradesh, India | |
| Accipere Pharmaceuticals Private Limited | ₹30.61 Lakh (FY 2025) | 0.0% | Kollam, Kerala, India | |||
| Macnis Pharmaceuticals Private Limited | ₹30.55 Lakh (FY 2023) | 27.0% | Delhi, India | |||
| Keryx Pharmaceuticals Private Limited | ₹30.46 Lakh (FY 2025) | 33.0% | Mohali, Punjab, India |
To see the full peer comparison of NRXN Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving NRXN Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for NRXN Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
NRXN Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
NRXN Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCN0502E1ZX | Uttar Pradesh | Active | 21 Nov 2020 |
To see the full GST registrations and return filing status of NRXN Pharmaceuticals Private Limited, buy the company report.
Recent activity
NRXN Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Gaurav Kumar was appointed as Managing Director on 10 Oct 2020.
Frequently asked questions
NRXN Pharmaceuticals is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 24 July 2020 (6+ years old) and is registered under CIN U24290UP2020PTC131583.
NRXN Pharmaceuticals has 2 current directors:
- Gaurav Kumar - Managing Director
- Neha Varshney - Director
The latest financial statements of NRXN Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of NRXN Pharmaceuticals is 09AAHCN0502E1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of NRXN Pharmaceuticals is U24290UP2020PTC131583. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
NRXN Pharmaceuticals was incorporated on 24 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of NRXN Pharmaceuticals by revenue are Viakos Pharmaceuticals Private Limited, Macklin Pharmaceuticals Private Limited, Accipere Pharmaceuticals Private Limited, Macnis Pharmaceuticals Private Limited, Keryx Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Gaurav Kumar was appointed as Managing Director on 10 Oct 2020. Neha Singh ceased to be Director on 10 Oct 2020. Neha Varshney was appointed as Director on 24 Jul 2020.
The registered office of NRXN Pharmaceuticals is at H.No.L – 2 Shashtri Nagar, Bareilly, Uttar Pradesh, India – 243122.
NRXN Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
NRXN Pharmaceuticals can be reached at its registered office: H.No.L – 2 Shashtri Nagar, Bareilly, Uttar Pradesh, India – 243122.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
